Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · IEX Real-Time Price · USD
2.215
-0.035 (-1.56%)
Jul 22, 2024, 10:06 AM EDT - Market open
Cardiff Oncology Employees
As of December 31, 2023, Cardiff Oncology had 32 total employees, including 31 full-time and 1 part-time employees. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$19,063
Profits / Employee
-$1,257,906
Market Cap
102.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
FibroGen | 486 |
Adicet Bio | 143 |
Omega Therapeutics | 94 |
IO Biotech | 68 |
VistaGen Therapeutics | 40 |
Sensus Healthcare | 35 |
Eledon Pharmaceuticals | 20 |
CRDF News
- 7 weeks ago - Cardiff Oncology to Present at the Jefferies Healthcare Conference - GlobeNewsWire
- 2 months ago - Cardiff Oncology to Present at Upcoming Investor Conferences in May - GlobeNewsWire
- 2 months ago - Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update - GlobeNewsWire
- 3 months ago - Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study - GlobeNewsWire
- 4 months ago - Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024 - GlobeNewsWire
- 5 months ago - Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC - GlobeNewsWire